Stay informed with the latest updates for the inheritable blood disorders community.

Sangamo Announces First Patient Treated in Hemophilia B Gene Therapy Trial
uniQure Confirms First Patient Dosed in Hemophilia B Gene…
Bayer Responds to NHF-HFA Joint Statement
New 3500 IU Vial Size Now Available for Idelvion®
Industry
Catalyst Updates on Phase 2/3 Trial of Subcutaneous Therapy
Catalyst Updates on Phase 2/3 Trial of Subcutaneous Therapy
NHF 70th: Pursuing Discovery of the Next Generation of Therapies
NHF 70th: Pursuing Discovery of the Next Generation of Therapies
Industry
New Medscape Activity Makes the Case for Gene Therapy
Sangamo Reports Positive Preliminary Data from Hemophilia Gene Therapy…
Industry
Spark Reports Progress on Hemophilia A Gene Therapy
Spark Reports Progress on Hemophilia A Gene Therapy
Industry
Court Issues Final Judgement in Shire/Roche Patent Lawsuit
Court Rules on Shire/Roche Preliminary Injunction
Medical
New Medscape Activity Features the Science Behind Gene Therapy
New Medscape Activity Features the Science Behind Gene Therapy
Medical
Shire Discontinuing Manufacture and Distribution of BEBULIN®
Shire Discontinuing Manufacture and Distribution of BEBULIN®
Medical
Inhibitor Webinar for Providers Available Now!
Inhibitor Webinar for Providers Available Now!
NBDF & Community
New Financial Assistance Program Available for Hemophilia Patients
New Financial Assistance Program Available for Hemophilia Patients
NBDF & Community
HANDI Highlights: Resources for Students Headed Off to College!
HANDI Highlights: Resources for Students Headed Off to College!
NBDF & Community
Grant Opportunity: 2019 HTRS Mentored Research Award Program
Grant Opportunity: 2019 HTRS Mentored Research Award Program
NHF Comments on Trump Administration Drug Pricing Blueprint
NHF Comments on Trump Administration Drug Pricing Blueprint
Peer-Reviewed Journal Summaries
Non-Attendance of Clinic Visits at Emory HTC the Focus of New Study
Non-Attendance of Clinic Visits at Emory HTC the Focus of New Study